News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,562 Results
Type
Article (40732)
Company Profile (189)
Press Release (676641)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (209590)
Career Advice (1931)
Deals (35082)
Drug Delivery (109)
Drug Development (79591)
Employer Resources (152)
FDA (15972)
Job Trends (15339)
News (348066)
Policy (32890)
Tag
Academia (2742)
Accelerated approval (10)
Adcomms (24)
Allergies (106)
Alliances (46408)
ALS (116)
Alzheimer's disease (1514)
Antibody-drug conjugate (ADC) (178)
Approvals (15964)
Artificial intelligence (361)
Autoimmune disease (36)
Automation (19)
Bankruptcy (332)
Best Places to Work (12326)
BIOSECURE Act (22)
Biosimilars (133)
Biotechnology (136)
Bladder cancer (99)
Brain cancer (38)
Breast cancer (387)
Cancer (3058)
Cardiovascular disease (246)
Career advice (1564)
Career pathing (23)
CAR-T (200)
CDC (28)
Cell therapy (556)
Cervical cancer (24)
Clinical research (65670)
Collaboration (1102)
Company closure (3)
Compensation (710)
Complete response letters (33)
COVID-19 (2432)
CRISPR (63)
C-suite (357)
Cystic fibrosis (118)
Data (3086)
Decentralized trials (2)
Denatured (22)
Depression (73)
Diabetes (368)
Diagnostics (6867)
Digital health (26)
Diversity (5)
Diversity, equity & inclusion (40)
Drug discovery (162)
Drug pricing (124)
Drug shortages (30)
Duchenne muscular dystrophy (134)
Earnings (96611)
Editorial (43)
Employer branding (21)
Employer resources (123)
Events (125776)
Executive appointments (906)
FDA (17706)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (996)
Gene editing (141)
Generative AI (31)
Gene therapy (421)
GLP-1 (870)
Government (4898)
Grass and pollen (6)
Guidances (181)
Healthcare (20647)
HIV (42)
Huntington's disease (30)
IgA nephropathy (44)
Immunology and inflammation (180)
Immuno-oncology (9)
Indications (40)
Infectious disease (2626)
Inflammatory bowel disease (164)
Inflation Reduction Act (10)
Influenza (70)
Intellectual property (124)
Interviews (326)
IPO (17160)
IRA (46)
Job creations (3422)
Job search strategy (1376)
Kidney cancer (14)
Labor market (55)
Layoffs (549)
Leadership (9)
Legal (7720)
Liver cancer (84)
Longevity (12)
Lung cancer (426)
Lymphoma (215)
Machine learning (10)
Management (43)
Manufacturing (422)
MASH (94)
Medical device (14480)
Medtech (14485)
Mergers & acquisitions (18725)
Metabolic disorders (921)
Multiple sclerosis (104)
NASH (20)
Neurodegenerative disease (131)
Neuropsychiatric disorders (39)
Neuroscience (2244)
NextGen: Class of 2025 (7093)
Non-profit (5026)
Now hiring (33)
Obesity (471)
Opinion (223)
Ovarian cancer (104)
Pain (119)
Pancreatic cancer (125)
Parkinson's disease (199)
Partnered (18)
Patents (316)
Patient recruitment (172)
Peanut (55)
People (57056)
Pharmaceutical (48)
Pharmacy benefit managers (21)
Phase I (20517)
Phase II (29090)
Phase III (21815)
Pipeline (1696)
Policy (190)
Postmarket research (2195)
Preclinical (8648)
Press Release (71)
Prostate cancer (149)
Psychedelics (41)
Radiopharmaceuticals (276)
Rare diseases (506)
Real estate (5736)
Recruiting (58)
Regulatory (22883)
Reports (52)
Research institute (2450)
Resumes & cover letters (339)
Rett syndrome (9)
RNA editing (7)
RSV (57)
Schizophrenia (95)
Series A (171)
Series B (117)
Service/supplier (9)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (156)
Sponsored (28)
Startups (3341)
State (2)
Stomach cancer (15)
Supply chain (82)
Tariffs (47)
The Weekly (57)
Vaccines (787)
Venture capital (55)
Weight loss (308)
Women's health (43)
Worklife (13)
Date
Today (100)
Last 7 days (398)
Last 30 days (2050)
Last 365 days (33475)
2025 (18170)
2024 (37313)
2023 (42382)
2022 (53016)
2021 (57342)
2020 (56695)
2019 (50584)
2018 (37410)
2017 (33678)
2016 (33120)
2015 (38525)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25653)
Location
Africa (733)
Alabama (69)
Alaska (7)
Arizona (208)
Arkansas (14)
Asia (42591)
Australia (6958)
California (7638)
Canada (2409)
China (717)
Colorado (334)
Connecticut (339)
Delaware (198)
Europe (95331)
Florida (1153)
Georgia (261)
Hawaii (1)
Idaho (61)
Illinois (685)
India (30)
Indiana (378)
Iowa (16)
Japan (238)
Kansas (107)
Kentucky (31)
Louisiana (15)
Maine (73)
Maryland (1089)
Massachusetts (5829)
Michigan (269)
Minnesota (476)
Mississippi (3)
Missouri (99)
Montana (32)
Nebraska (25)
Nevada (83)
New Hampshire (72)
New Jersey (2168)
New Mexico (31)
New York (2160)
North Carolina (1195)
North Dakota (10)
Northern California (3360)
Ohio (250)
Oklahoma (17)
Oregon (38)
Pennsylvania (1641)
Puerto Rico (18)
Rhode Island (35)
South America (1128)
South Carolina (36)
South Dakota (1)
Southern California (2878)
Tennessee (128)
Texas (1159)
United States (28773)
Utah (230)
Virginia (197)
Washington D.C. (72)
Washington State (663)
West Virginia (4)
Wisconsin (77)
717,562 Results for "20".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment
Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.
May 15, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Recursion Downsizes by 20% To Boost Cash Position
As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027.
June 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
June 23, 2025
·
3 min read
Press Releases
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
June 18, 2025
·
5 min read
Press Releases
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
June 17, 2025
·
5 min read
VC Financings Drop 20% in Q1 but Megarounds Keep Median Deal Size High
Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first three months of this year, headlined by a clutch of massive funding rounds.
May 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL
June 18, 2025
·
1 min read
Press Releases
FUJIFILM VisualSonics Launches the Vevo F2 LAZR-X20 Photoacoustic Imaging Platform for Preclinical Ultrasound
June 27, 2025
·
3 min read
Press Releases
Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share
July 9, 2025
·
7 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 20, 2025
June 23, 2025
·
1 min read
1 of 71,757
Next
